Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Marsh & McLennan Affiliate To Buy Bluefin Insurance Group

Published 11/14/2016, 08:10 PM
Updated 07/09/2023, 06:31 AM
CB
-
MMC
-
EG
-
CNA
-

Marsh, a wholly owned subsidiary of Marsh & McLennan Companies, Inc. (NYSE:MMC) has inked a deal to acquire Bluefin Insurance Group Limited, a unit of AXA Group.

The acquisition is slated to be closed by the first quarter of 2017, subject to certain regulatory approvals. Marsh intends to combine Bluefin and Jelf, acquired last year – into one single business unit. Phil Barton, the present CEO of Jelf, will lead the mergedunit. A management team comprising employees from both Bluefin and Jelf will also be formed post transaction.

We note that since its buyout Jelf has facilitated Marsh in every possible way to deliver the best value and expertise to cater to the needs of clients.

On the other hand, Bluefin boasts a significance presence in almost 45 locations across the U.K. The company provides guidance on creating insurance solutions to more than 150,000 businesses and individuals through its extensive broker network and growing Managing General Agents business.

Hence, the latest acquisition and the subsequent integration with Jelf will enable Marsh to serve over 250,000 clients in 80 locations. The move will also add roughly 400 network broker members alongside strong affinity and digital offerings.

The new unit is expected to become one of the leading insurance brokers for mid-size and SME companies in the U.K. The merged entity is also likely to offer high quality technical advice, bespoke products and unique services including claims consultancy and risk management. Intelligent risk insights to enable companies to combat emerging risks like cyber and solution to people-related issues through a strong employee benefits team is another positive.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This acquisition and the ensuing merger of the two business units will ensure the best risk and insurance advice to businesses of all sizes. Marsh is currently investing in new policies, products and analytic tools to help businesses manage future risks and uncertainties.

MARSH &MCLENNAN Price

Zacks Rank & Stocks to Consider

Marsh & McLennan presently carries Zacks Rank #3 (Hold).You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Some better-ranked players from the insurance space include CNA Financial Corporation (NYSE:CNA) , Chubb Ltd. (NYSE:CB) and Everest Re Group Ltd. (NYSE:RE) . All of these stocks carry a Zacks Rank #2 (Buy).

CNA Financial delivered positive surprises in three of the last four quarters but with an average miss of 18.69%.

Chubb beat expectations in three of the last four quarters with an average beat of 4.06%

Everest Re delivered positive surprises in three of the last four quarters with an average beat of 25.64%.

Zacks’ Best Private Investment Ideas

In addition to the recommendations that are available to the public on our website, how would you like to follow all Zacks' private buys and sells in real time?

Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Starting today, for the next month, you can have unrestricted access. Click here for Zacks' private trades >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


MARSH &MCLENNAN (MMC): Free Stock Analysis Report

CHUBB LTD (CB): Free Stock Analysis Report

EVEREST RE LTD (RE): Free Stock Analysis Report

CNA FINL CORP (CNA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.